期刊： CURRENT TREATMENT OPTIONS IN RHEUMATOLOGY, 2023; 9 (3)
Purpose of reviewExercise therapy is the first line treatment for patients with knee and hip osteoarthritis (OA) but is consistently underutilized. In......
期刊： CURRENT TREATMENT OPTIONS IN RHEUMATOLOGY, 2023; 9 (4)
Purpose of reviewTo analyze and provide an update of the current therapeutic strategies on immune checkpoint inhibitor-related myositis, including for......
期刊： CURRENT TREATMENT OPTIONS IN RHEUMATOLOGY, 2023; 9 (3)
Purpose of the reviewThis narrative review highlights recent literature pertaining to available intra-articular (IA) therapeutics such as corticostero......
期刊： CURRENT TREATMENT OPTIONS IN RHEUMATOLOGY, 2023; 9 (4)
Purpose of ReviewImmune-mediated necrotizing myositis (IMNM) is a rare autoimmune disorder characterized by proximal muscle weakness, elevated creatin......
期刊： CURRENT TREATMENT OPTIONS IN RHEUMATOLOGY, 2023; 9 (3)
Purpose of reviewThere is increasing recognition that virtual tools, enabled by the internet and telecommunications technology, can increase access to......
期刊： CURRENT TREATMENT OPTIONS IN RHEUMATOLOGY, 2023; 9 (3)
Purpose of the reviewKnee osteoarthritis is a progressive degenerative condition that affects quality of life due to chronic pain, decreased functiona......
期刊： CURRENT TREATMENT OPTIONS IN RHEUMATOLOGY, 2023; 9 (3)
Purpose of reviewPatient-centred care for people with osteoarthritis requires shared decision making. Understanding and considering patients' preferen......
期刊： CURRENT TREATMENT OPTIONS IN RHEUMATOLOGY, 2023; 9 (2)
Purpose of ReviewImmune-mediated necrotizing myositis (IMNM) is the latest identified subgroup of idiopathic inflammatory myopathies (IIM). IMNM delin......
期刊： CURRENT TREATMENT OPTIONS IN RHEUMATOLOGY, 2023; 9 (3)
Purpose of ReviewAlthough intra-articular (IA) mineralization resulting from calcium crystal deposition is common in osteoarthritis (OA), its clinical......
期刊： CURRENT TREATMENT OPTIONS IN RHEUMATOLOGY, 2023; 9 (4)
Purpose of ReviewThis review describes the greater trochanteric pain syndrome in terms of its clinical presentation, diagnosis, and management.Recent ......
期刊： CURRENT TREATMENT OPTIONS IN RHEUMATOLOGY, 2023; 9 (1)
Key messages & BULL; Gynecologic presentations of GPA are rare, especially in the uterus, fallopian tube, ovary, and vagina. & BULL; Diagnosis......
期刊： CURRENT TREATMENT OPTIONS IN RHEUMATOLOGY, 2023; 9 (4)
Purpose of ReviewSystemic sclerosis (SSc)and myositis are two different entities that may coexist as an overlap syndrome. Immunological biomarkers suc......
期刊： CURRENT TREATMENT OPTIONS IN RHEUMATOLOGY, 2023; 9 (4)
Purpose of reviewSystemic sclerosis-associated interstitial lung disease (SSc-ILD) and idiopathic pulmonary fibrosis (IPF) are fatal fibrotic lung dis......
期刊： CURRENT TREATMENT OPTIONS IN RHEUMATOLOGY, 2023; 9 (4)
Purpose of the ReviewSystemic sclerosis (SSc) is a condition of dermal and visceral scar formation characterized by immune dysregulation and inflammat......
期刊： CURRENT TREATMENT OPTIONS IN RHEUMATOLOGY, 2023; 9 (2)
Purpose of reviewThis review focuses on the role of psychologists in the assessment and treatment of fibromyalgia syndrome (FMS), a highly prevalent c......
